Skip to main content
. 2021 Feb 22;6:79. doi: 10.1038/s41392-020-00455-6

Fig. 3.

Fig. 3

Cell therapy of injured cardiac tissues. iPSCs can differentiate into functional cardiomyocytes in vitro. Heart-derived cells can differentiate into many types of heart cells. GMT or GHMT mixtures reprogram mouse fibroblasts to differentiate into iCMs, and Smarcd3 reprograms mouse fibroblasts to differentiate into cardiac progenitor cells in vitro. MSCs differentiate into CMs in the presence of 5-aza or in coculture with cardiac progenitor cells. However, reprogramming human fibroblasts requires GMT or GHMT mixtures and troponin, MESP1, ESRRγ and ZFPM2, was well as miR-1 and miR-133. Human fibroblasts can be transformed into cardiac progenitor cells with c-ETS2 and MESP1